UBS Oncology Impact Fund L.P. — insider trades

Stock trades UBS Oncology Impact Fund L.P. reported on SEC Form 4 at HOWL Werewolf Therapeutics, Inc., ITOS iTeos Therapeutics, Inc..

• Dec 4, 2025: sold 199,732 shares of HOWL Werewolf Therapeutics, Inc. ($183K)
• Dec 1, 2025: sold 141,927 shares of HOWL Werewolf Therapeutics, Inc. ($137K)
• Nov 25, 2025: sold 195,666 shares of HOWL Werewolf Therapeutics, Inc. ($180K)
• Nov 20, 2025: sold 160,103 shares of HOWL Werewolf Therapeutics, Inc. ($148K)
• Nov 17, 2025: sold 209,652 shares of HOWL Werewolf Therapeutics, Inc. ($201K)
• Nov 12, 2025: sold 213,529 shares of HOWL Werewolf Therapeutics, Inc. ($241K)
• Nov 6, 2025: sold 242,890 shares of HOWL Werewolf Therapeutics, Inc. ($296K)
• Nov 3, 2025: sold 295,043 shares of HOWL Werewolf Therapeutics, Inc. ($392K)
• Oct 29, 2025: sold 276,017 shares of HOWL Werewolf Therapeutics, Inc. ($446K)
• May 13, 2025: sold 1,031,931 shares of ITOS iTeos Therapeutics, Inc. ($8.32M)